Skip to main content
Erschienen in: Health and Quality of Life Outcomes 1/2015

Open Access 01.12.2015 | Research

Do patient-reported outcome measures cover personal factors important to people with rheumatoid arthritis? A mixed methods design using the International Classification of Functioning, Disability and Health as frame of reference

verfasst von: Mona Dür, Michaela Coenen, Michaela Alexandra Stoffer, Veronika Fialka-Moser, Alexandra Kautzky-Willer, Ingvild Kjeken, Răzvan Gabriel Drăgoi, Malin Mattsson, Carina Boström, Josef Smolen, Tanja Alexandra Stamm

Erschienen in: Health and Quality of Life Outcomes | Ausgabe 1/2015

Abstract

Background

Personal factors (PFs) are internal factors that determine functioning and the individuals’ experience of disability. Their coverage by patient-reported outcome measures (PROMs) has not been examined in rheumatoid arthritis (RA) so far. The aims of this study were to identify PFs important in the life stories of people with RA and to determine their coverage by PROMs used in RA.

Methods

The qualitative data of people with RA was explored to identify PFs. Additionally a systematic literature search was conducted to find PROMs used in RA. PROMs items were linked to the components, domains and categories of the International Classification of Functioning, Disability and Health (ICF) to determine the coverage of important PFs by PROMs.

Results

Twelve PFs were found to be important in the life stories of people with RA. The PFs coping and reflecting about one’s life in an optimistic way were covered most frequently, each by 14 of the 42 explored PROMs, while job satisfaction was not covered at all. The London Coping with Rheumatoid Arthritis Questionnaire, General Self-Efficacy Scale, Arthritis Self-Efficacy Scale, Rheumatoid Arthritis Self-Efficacy Questionnaire and Revised Ways of Coping Inventory covered most PFs. Nineteen PROMs did not cover any of the PFs.

Conclusion

Several PFs were identified as important in the life stories of people with RA, but only 55% of the PROMS covered some of these PFs. When evaluating PFs important to people with RA, health professionals should be alert on which PROMs can be used to assess which PFs.
Hinweise
Veronika Fialka-Moser deceased.

Competing interests

The authors declare that they have no competing interests.

Authors’ contributions

MD, JS, and TAS were involved into conception and design, the acquisition of data, the analysis and interpretation of data, wrote the draft manuscript, and gave final approval of the manuscript. RD assisted the data acquisition, analysis and interpretation, and the draft version, and finally gave advice on editing of manuscript. AK-W and VF-M gave substantial contributions to conception and design, supported the acquisition of the data, have been involved in revising the draft manuscript critically, and finally approved the manuscript considered for publication. MC, IK, MAS, MM and CB supported the analysis and interpretation of the data, contributed substantially to the draft manuscript and approved the final version. The authors have taken an active part in the study and take responsibility for its contents. The FWF did not have any influence on the manuscript. All authors read and approved the final manuscript.
Abkürzungen
ASES
Arthritis self-efficacy scale
GSES
General self-efficacy scale
HAQ
Health assessment questionnaire
ICF
International classification of functioning, disability and health
LCRAQ
London coping with rheumatoid arthritis questionnaire
MDHAQ
Multidimensional health assessment questionnaire
PF (s)
Personal factor (s)
PROM (s)
Patient-reported outcome measure (s)
RA
Rheumatoid arthritis
RASE
The rheumatoid arthritis self-efficacy questionnaire
WOC-R
Revised ways of coping inventory

Background

Rheumatoid arthritis (RA) is a chronic autoimmune disease, characterized by joint inflammation, pain, joint swelling, morning stiffness, and fatigue which may lead to loss of functioning in daily life [1]. The prevalence ranges from 0,5-2% and is 3 - 4 times higher in women than in men [2]. However, the current understanding of the burden of the disease comprises not only clinical symptoms, but also other aspects that have an impact on living with RA, including environmental factors and personal factors, such as people’s social support or self-efficacy [3-5].
The International Classification of Functioning, Disability and Health (ICF) [6] is a common conceptual framework used to understand, describe and measure the dimensions of human functioning, disability and health [7]. Within the ICF, an individual’s functioning is conceptualized as result of the interplay between body functions and structures, activities and participation and contextual factors that include environmental and personal factors (PFs) [6].
PFs have played a tangential part in relation to ICF-based health outcome research. In the ICF, PFs are defined as internal factors that determine functioning and the individuals’ experience of disability. PFs comprise “features of the individual” such as coping, social background and psychological factors impacting health outcomes [6]. However, even if a few researchers have explored PFs through consensus processes [8], systematic reviews [9] or qualitative interviews with patients [10], they are not yet classified according to the ICF “taxonomy” [6,7].
For example, the RA ICF core set was developed to provide a set of categories that best describes the problems of functioning of people with RA [11]. Within three validation studies based on qualitative data several PFs were identified as meaningful which have not been covered by the ICF core sets [12-15]. Further, even though single PFs have been explored in people with RA [16,17], they have been left out in the examination of the coverage of the perspectives of patients with RA by patient-reported outcome measures (PROMs), as it has been done in other chronic diseases [18-20]. Thus, it is unclear how PROMs cover PFs important to people with RA. Additionally, PFs and their meaning to people with RA may change over time and the course of disease [21,22]. Hence, they need to be explored within a long-term perspective over the life course.
Furthermore, the new and effective biologic therapies facilitate the inclusion of other important aspects such as PFs as targets of non-pharmacological treatment of people with RA [6,23,24]. For example, interventions targeting PFs, such as coping strategies or medication beliefs, could support individuals to achieve their fullest potential on functioning, to reduce the impact of RA [24,25], and to increase medication adherence [26]. To assess the need for or to evaluate non-pharmacological treatment in clinical practice or rehabilitation targeting PFs, health professionals and researchers should be alert on which PROMs cover which PFs.
The aims of this study were to identify PFs important in the life stories of people with RA and to determine their coverage by PROMs used in RA.

Methods

We used a mixed methods design consisting of a qualitative analysis, a systematic literature search and a linking process. The current project was part of a larger study [27,28].

Exploration of qualitative data to identify personal factors important in the life stories of people with RA

Firstly, a secondary analysis of qualitative data of a previous study [29,30] was conducted. In the respective study, patients from the rheumatologic outpatient clinic of the Medical University of Vienna, Austria, diagnosed with RA [31] were asked for participation. A small sample size of 15 participants with a diverse range was aimed to gather rich and meaningful data [32]. Recruitment used a maximum variation sampling strategy [33] in terms of sex, age, former professional status and disease duration. Inclusion criteria were “being early retired” at the time of the interviews, having past employment experience (≥20 hours per week), no history of psychiatric and/or other neuro-motor disease and German as first language. Since we were interested in the identification of PFs which could be complex, such as coping or resilience, we decided to use people’s life stories and to follow the biographical narrative interpretative method (BNIM) [33,34]. In accordance to the study aim the interviews’ verbatim transcripts of the life stories were used to determine PFs which were important over the life and disease course of people with RA. Therefore, each transcript was analyzed by two researchers independently (MD, MS, and TAS). In case of disagreement, each case was discussed in a research panel of three people who together made a final informed decision, whether or not a certain PF was encompassed in the respective life story. PFs which were found among different life stories were identified based on the exploration of people’s interpretation of their life’s experience and their biography [34] and used for the exploration of their coverage by PROMs. A flow chart of the different steps of the BNIM is depicted in Figure 1. For detailed information we refer to further literature [33,34].

Systematic literature search to find PROMs used in RA

Secondly, we conducted a systematic literature search in 2013 using PubMed, CINAHL and PsycInfo to find PROMs used in RA and to extract their items. The following combination of keywords was used to search the articles: [(rheumatoid arthritis)] AND [(outcome) OR (assessment) OR (instrument) OR (measure) OR (questionnaire)] AND [(self-reported) OR (patient-reported) OR (patient perspective)]. For inclusion, articles had to be written in English and published in a peer-reviewed journal and the description of the use or development of at least one PROM had to be contained in the title or the abstract. Candidate articles were independently reviewed by two researchers (MD and AB) using a data extraction form, to identify the descriptions of PROMs. A PROM was included when the following criteria were applied: assessing functioning and/or functional health and/or those PFs which were identified in the qualitative analyses. PROMs items which were not provided within these articles were obtained from reference checking or on request from their authors. PROMs specifically designed for children or adolescents and single-VAS-assessments for disease activity of RA were excluded.

Linking process to determine the coverage of important personal factors by PROMs

Finally, we determined which PFs were covered by which PROMs using the ICF [6] as reference. Items of the PROMs were linked to ICF categories by two researchers (MD and MC). In case of disagreement an informed decision was made by one further researcher skilled and experienced in the ICF linking process (TAS). The linking process followed a standard procedure by the use of the current ICF-linking rules [35]. Concerning the complexity of certain items, we applied the ICF-linking rule referring to items encompassing different constructs, an example is shown in Figure 2. Articles providing ICF categories linked to the selected PROMs were used.
The linked ICF categories of each PROM were compared to the PFs from the qualitative data by mapping them to each other. Finally, PROMs were explored in order to report how many PROMs were available to assess each PF and those PFs for which no PROM existed. An example is given in Figure 2.

Ethical considerations

Participants received information about study procedures and ethical considerations and gave written and oral informed consents. Confidentiality was guaranteed and names were changed in the given examples. The study was approved by the ethics committee of the Medical University of Vienna, Austria.

Results

Personal factors important in the life stories of people with RA

For the current study, we used the data of 15 people with RA, 11 women and 4 men with a median age of 54 years and disease duration of 11 years [29,30]. Demographic data is depicted in Table 1.
Table 1
Demographic data of the participants
 
Women
Men
n (%) Total
11 (73)
4 (27)
n (%) International Standard Classification of Education (ISCED) level 3: completed vocational education or secondary education premising the access to higher education
6 (55)
3 (75)
Median Age (interquartile range)
52 (43–61)
56 (42–58)
Median Disease duration (interquartile range)
10 (8–20)
14 (10–26)
In the secondary analysis of the life stories of people with RA the following 12 PFs were identified as being important: Adaptation to changed living conditions; coping; eating habits and weight concerns; involvement into disease management; job satisfaction; meaningful activities for the individual and/or the societal context; own attitudes; reflecting about one’s life in an optimistic way; resilience; self-efficacy; sense of coherence and social appreciation.
In the following section, we give two examples of important PFs: In the life story of Hans, a 58 years old varnisher, we identified adaptation to changed living conditions. Hans did not get a job after he had left the previous one. Thus, his life story contained several descriptions on changes which were adaptations to living with RA:
“Depressing when you suddenly become useless at the age of 40, not knowing how life will go on and how to get oneself and one’s family. So, my wife worked half time and I took care of the children, as far as that was possible”. (First interview, lines 51–53)
Another example is Maria, a 42 years old woman. She did not let the disease “rule” her life and supported others to care about their health and wellbeing. Finally, Maria became an “advocate” for people with RA. We identified self-efficacy and involvement into disease management when she told about her engagement in acquiring knowledge and skills.
“What I wanted to know was how to handle it [the disease]? So, I asked my physician [rheumatologist] to prepare me for the case that the worst happens and we talked it through. I have written down everything. In the case I found myself in troubles, I looked through my notes and could help myself”. (First interview, lines 537–546)
“My ambition spurred me on, not to accept everything related to the disease and to let it rule my life. I have bought medical books, attended specialist conferences [on rheumatic diseases], I went to libraries and studied [RA specific] drugs and their side effects. I started to understand the physician a little when he talked about the medication. I felt that I could have a determining influence on the decision which drug should be tried next”. (First interview, lines 687–701) “I realized that meanwhile I was engaged in the management of my disease to the same extent as I was engaged in my job formerly”. (First interview, lines 719–721)
Three PFs were found to be important in the life stories of women only. These were reflecting about one’s life in an optimistic way, involvement into disease management and job satisfaction. While coping and meaningful activities for the individual and/or the social context was important in the life story of all men, the same was true for own attitudes in women. The frequency and percentage of identified PFs per sex are depicted in Table 2.
Table 2
Frequency of personal factors per sex
R
Personal factors
n (%)
f (%)
m (%)
1
Own attitudes
13 (87)
11 (100)
2 (50)
2
Adaptation to changed living conditions
11 (73)
9 (82)
2 (50)
3
Meaningful activities for the individual and/or the social context
12 (80)
8 (73)
4 (100)
4
Eating habits and weight concerns
10 (67)
8 (73)
2 (50)
5
Coping
9 (60)
5 (45)
4 (100)
6
Reflecting about one’s life in an optimistic way
7 (47)
7 (64)
0
6
Involvement into disease management
7 (47)
7 (64)
0
6
Self-efficacy
7 (47)
6 (55)
1 (25)
7
Sense of Coherence
6 (40)
4 (36)
2 (50)
8
Job satisfaction
5 (33)
5 (45)
0
9
Social appreciation
4 (27)
3 (27)
1 (25)
9
Resilience
4 (27)
2 (18)
2 (50)
Abbr.: R = Rank, n = number, f = female, m = male.

PROMs used in RA

The systematic literature search resulted in 1280 hits, of which 831 were excluded due to 107 duplicates and 724 irrelevant articles. Finally, 449 articles were used to identify the PROMs used in RA, as described in Figure 3.
In total forty-two PROMs met our inclusion criteria. They are listed and described in Table 3.
Table 3
Characteristics of the identified patient-reported outcome measures
Abbreviations
Names of patient-reported outcome measures
Items
AIMS2-SF
Arthritis Impact Measurement Scales Short Form [36]
26
APaQ
Activity Participation Questionnaire [37]
2
ASES
Arthritis Self-Efficacy Scale [38]
20
B-WOC-R
Brief Revised Ways of coping inventory [39]
18
BRAF MDQ
Bristol Arthritis Fatigue Multi-Dimensional Questionnaire [40]
20
BRAF NRS
Bristol Arthritis Fatigue Numerical Rating Scale [40]
3
CFS
Chalder Fatigue Scale [41]
11
CIS 20R
Checklist Individual Strength [42]
20
CIS 8R
Checklist Individual Strength [42]
8
C-RAQ
Coping with Rheumatoid Arthritis Questionnaire [25]
20
DRP
Disease Repercussion Profile [43]
6
EC-17
Effective Musculoskeletal Consumer Scale (Short Form) [44]
17
EQ-5D
EuroQuoL Health questionnaire [45]
5
FACIT-F
Functional Assessment Chronic Illness Therapy (Fatigue) [46]
13
FSS
Fatigue Severity Scale [47]
9
GSES
General Self-Efficacy Scale [48,49]
10
HADS
Hospital Anxiety and Depression Scale [50]
14
HAQ
Health Assessment Questionnaire [51]
20
HAQ-II
Health assessment questionnaire ii [52]
10
HAQ-DI
Health Assessment Questionnaire Disability Index [53]
20
JP SES
Joint Protection Self-efficacy Scale [54]
10
LCRAQ
London Coping with Rheumatoid Arthritis Questionnaire [55]
36
LOT-R
Life Orientation Test-Revised [56]
8
MAF
Multi-dimensional Assessment of Fatigue [57]
15
MFI
Multi-dimensional Fatigue Inventory [58]
20
MHAQ
Modified Health Assessment Questionnaire [59]
8
MHLC - C
Multidimensional Health Locus of Control C-Form [60]
18
PI-HAQ
Personal Impact Health Assessment Questionnaire [61]
20
PRO-CLARA
Patient Reported Outcome - Clinical Arthritis Activity [62]
21
RAID
Rheumatoid Arthritis Impact of Disease score [63]
12
RAPID 3
Routine Assessment of Patient Index Data [64]
24
RAQoL
Rheumatoid Arthritis Quality of life [65]
30
ROAD
Recent-Onset Arthritis Disability Index [66]
12
RASE
Rheumatoid Arthritis Self-Efficacy Questionnaire [67]
28
SACRAH
Score for Assessment & Quantification of Chronic Rheumatoid Affections of the Hands [68]
23
SF-36
Short-Form Health Survey 36-item [69,70]
36
SOC-13
Sense of Coherence scale-13 [71]
13
SSQS & SQT
Social Support Questionnaire Transactions & Satisfaction with supportive transactions [72]
46
SSS
MOS Social Support Survey [73]
20
WOC-R
Revised Ways of Coping Inventory [74]
50
10 ADLMDHAQ
10 Activities of Daily Living Multidimensional Health Assessment Questionnaire [75]
10
14 ADLMDHAQ
14 Activities of Daily Living Multidimensional Health Assessment Questionnaire [75]
14

PROMs coverage of important personal factors

The ICF categories linked to the items of eight PROMs [36,45,51,59,64,68,70,76] were used from existing literature [28,77,78]. The mapping of PFs to the PROMs is depicted in Table 4.
Table 4
Coverage of personal factors by patient-reported outcome measures
 
Important personal factors
PROMs
Adaptation to changed living conditions
Coping
Eating habits & weight concerns
Involvement into disease management
AIMS2-SF
    
APaQ
    
ASES
 
+
 
+
B-WOC-R
 
+
  
BRAF MDQ
    
BRAF NRS
 
+
  
CFQ
    
CIS 20R
    
CIS 8R
    
C-RAQ
 
+
  
DRP
    
EC-17
 
+
 
+
EQ-5D
    
FACIT-F
 
+
  
FSS
    
GSES
 
+
  
HADS
    
HAQ
    
HAQ-II
    
HAQ-DI
    
JP SES
    
LCRAQ
+
+
+
+
LOT-R
    
MAF
    
MFI
    
MHAQ
    
MHLC-C
 
+
  
PI-HAQ
    
PRO-CLARA
    
RAID
 
+
 
+
RAPID 3
 
+
  
RASE
 
+
  
RAQoL
    
ROAD
    
SACRAH
    
SF-36
    
SOC-13
    
SSQT & -S
    
SSS
    
WOC-R
 
+
 
+
10 ADLMDHAQ
    
14 ADLMDHAQ
 
+
  
 
Important personal factors
PROMs
Job satisfaction
Meaningful activities for the individual/the social context
Own attitudes
Reflecting about one’s life in an optimistic way
AIMS2-SF
    
APaQ
    
ASES
  
+
 
B-WOC-R
   
+
BRAF MDQ
    
BRAF NRS
    
CFQ
    
CIS 20R
    
CIS 8R
    
C-RAQ
   
+
DRP
   
+
EC-17
   
+
EQ-5D
    
FACIT-F
 
+
 
+
FSS
    
GSES
  
+
+
HADS
   
+
HAQ
    
HAQ-II
    
HAQ-DI
    
JP SES
    
LCRAQ
  
+
+
LOT-R
   
+
MAF
    
MFI
    
MHAQ
    
MHLC-C
  
+
+
PI-HAQ
    
PRO-CLARA
    
RAID
    
RAPID 3
    
RASE
  
+
+
RAQoL
   
+
ROAD
    
SACRAH
    
SF-36
  
+
 
SOC-13
 
+
 
+
SSQT & -S
    
SSS
    
WOC-R
   
+
10 ADLMDHAQ
    
14 ADLMDHAQ
    
 
Important personal factors
PROMs
Resilience
Self-efficacy
Sense of coherence
Social appreciation
AIMS2-SF
    
APaQ
    
ASES
 
+
+
 
B-WOC-R
+
+
  
BRAF MDQ
    
BRAF NRS
    
CFQ
    
CIS 20R
    
CIS 8R
    
C-RAQ
+
+
  
DRP
    
EC-17
 
+
  
EQ-5D
    
FACIT-F
+
   
FSS
    
GSES
+
+
+
 
HADS
+
   
HAQ
    
HAQ-II
    
HAQ-DI
    
JP SES
 
+
  
LCRAQ
+
+
 
+
LOT-R
+
 
+
 
MAF
+
   
MFI
 
+
  
MHAQ
    
MHLC-C
 
+
  
PI-HAQ
    
PRO-CLARA
    
RAID
    
RAPID 3
+
   
RASE
+
+
  
RAQoL
 
+
  
ROAD
    
SACRAH
    
SF-36
    
SOC-13
  
+
 
SSQT & -S
    
SSS
    
WOC-R
+
+
  
10 ADLMDHAQ
    
14 ADLMDHAQ
    
PROMs = abbreviated names of patient-reported outcome measures; + = personal factor is covered by the specific patient-reported outcome measures.
The PFs coping and reflecting about life in an optimistic way were covered most frequently (each by 14 PROMs), followed by resilience and self-efficacy (each by 12 PROMs). Compared to that, job satisfaction was not covered by any of the PROMs. The PF own attitudes was covered by six, involvement into disease management by five, sense of coherence by four and meaningful activities by two PROMs. Adaptation to changed living conditions, social appreciation and eating habits and weight concerns were covered once, each by the London Coping with Rheumatoid Arthritis Questionnaire (LCRAQ) [79].
The LCRAQ covered most (nine) PFs, followed by the General Self-Efficacy Scale (GSES) [48,49] which covered six PFs. The Arthritis Self-Efficacy Scale (ASES) [38], the Rheumatoid Arthritis Self-Efficacy Questionnaire (RASE) [67] and the Revised Ways of Coping Inventory (WOC-R) [74] captured five PFs each. Nineteen of the 42 explored PROMs covered no PF, including the different versions of the Health Assessment Questionnaire (HAQ) except the 14 Activities of Daily Living Multidimensional HAQ (14 ADLMDHAQ) [51-53,61,75], as shown in Table 4.

Discussion

In the current study we identified 12 PFs being important in the life stories of people with RA and explored their coverage by 42 PROMs used in RA. The results of this study can support health professionals and researchers in their selection of which PROMs to use, when assessing the need for or evaluating the effect of non-pharmacological treatment in clinical practice or rehabilitation [80] targeting the identified PFs.
PFs which were found to be important to people with RA could get more emphasis in ICF-based health outcome research. For example, self-efficacy was found to facilitate the maintenance of physical activity [4] and to decrease fatigue [81], pain [82] and the development of cardiovascular risk [83,84]. Since cardiovascular diseases account for approximately 50% of mortality [85], the prevention of cardiovascular risk is an important target in the disease management of RA [86] including pharmacological and non-pharmacological methods [87]. Thus, health outcome research focusing on PFs with strong evidence for their health determining effect could be of great value to support individuals achieving their fullest functioning and health.
Due to unequal proportion of female and male participants, the identified gender differences of PFs need to be treated with caution. The findings could indicate a difference in the meaning of these PFs in the life stories between women and men with RA. Therefore, the selection of the outcomes and related PROMs should take into account potential gender differences to consider the preferences and values regarding PFs of women and men in the evaluation of health care interventions.
Even though, most of the explored PROMs were not designed to assess a range of PFs, one PROM was outstanding in its coverage of PFs: the LCRAQ which could be used to address most of the identified PFs. The GSES could be employed to measure six PFs. Additionally, the ASES, the RASE and the WOC-R were found to assess five different PFs, respectively. While the PFs coping, reflecting about one’s life in an optimistic way and sense of coherence could be assessed by all of these PROMs, adaptation to changed living conditions, eating habits and weight concerns, and social appreciation was found to be covered by the LCRAQ only. In addition, the PROMs which covered most of the PFs, could be used to measure the PFs own attitudes (except the WOC-R) and resilience (except the ASES). Consequently, one of these PROMs could be selected for the evaluation of health care interventions having regard to the different PFs important in the life stories of people with RA. However, for the use in clinical practice and research, other psychometric properties and applicability in different cultural contexts need to be considered.
Commonly used PROMs in clinically routine, e.g. the HAQ could be combined with others. Only the 14 ADLMDHAQ [75] covers PFs (n = 2), while the other versions of the HAQ do not cover any of the PFs. In addition, it would be interesting to develop RA specific PROMs that address adaptation to changed living conditions, social appreciation, eating habits and weight concerns, job satisfaction and meaningful activities, since these PFs have rarely been addressed in the PROMs. In the clinical routine and rehabilitation, health professionals such as nurses, occupational therapists or physiotherapists, may use other assessments and thus, could address PFs to complement and/or to conduce to success of pharmacological treatment for people with RA [26].
This research had some limitations. An inclusion of PROMs published in various languages could give valuable information about their potential utilization to assess PFs. Another study could include PFs important to patients of younger age to determine their coverage of PROMs, based on previous research [88]. In addition, further studies could focus on the perspectives of patients of different cultural backgrounds or specific person groups such as parents or patients with recent onset. The so called member checking method could have contributed to the credibility of the findings. In the current project we explored the content validity of PROMs, referring to their coverage of concepts which are relevant to the target population [89]. Despite determining PROMs’ content validity, a critical appraisal of other measurement properties could have provided additional important information. However, we did not explore other psychometric properties of the selected PROMs since this was not the focus of our study. Additional studies are warranted to generalize the findings of the current project to other people with RA.

Conclusion

Taken together, the identified PFs are important in the life stories of people with RA and could be addressed in clinical practice and rehabilitation by different health professionals in order to support their patients’ functioning and health. The LCRAQ, the GSES, the ASES, the RASE and the WOC-R could be used when assessing the need for or evaluating health care interventions targeting the identified PFs and thus contribute to an increasing benefit for people with RA. Furthermore the findings can be used for further development of existing PROMs and to guide their use in clinical practice, rehabilitation and research.

Acknowledgements

We thank patients for their participation and the important contributions for this study. We thank authors for the provision of “unavailable” PROMs. Furthermore we thank Herta Resch for the interview transcription and Alexa Binder for extracting relevant information about PROMs in the respective literature. The current study, as a part of a larger project was funded by the Austrian Science Fund (FWF): [P21912-B09]. The FWF did not review the manuscript nor had any influence over the manuscript content.

Funding

Partly funded by a restricted grant of the Austrian Science Fund (FWF): [P21912-B09].

Data sharing statement

Data from this study will be made available upon request to the corresponding author (TAS), in accordance with relevant guidelines from the funding agency and the ethical approval of the ethic committee of the Medical University of Vienna, Austria.
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://​creativecommons.​org/​licenses/​by/​4.​0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://​creativecommons.​org/​publicdomain/​zero/​1.​0/​) applies to the data made available in this article, unless otherwise stated.

Competing interests

The authors declare that they have no competing interests.

Authors’ contributions

MD, JS, and TAS were involved into conception and design, the acquisition of data, the analysis and interpretation of data, wrote the draft manuscript, and gave final approval of the manuscript. RD assisted the data acquisition, analysis and interpretation, and the draft version, and finally gave advice on editing of manuscript. AK-W and VF-M gave substantial contributions to conception and design, supported the acquisition of the data, have been involved in revising the draft manuscript critically, and finally approved the manuscript considered for publication. MC, IK, MAS, MM and CB supported the analysis and interpretation of the data, contributed substantially to the draft manuscript and approved the final version. The authors have taken an active part in the study and take responsibility for its contents. The FWF did not have any influence on the manuscript. All authors read and approved the final manuscript.
Literatur
1.
Zurück zum Zitat WHO. The Burden of Musculoskeletal Conditions at the Start of the New Millenium, Technical Report Series,No.919. Geneva: World Health Organization; 2003. WHO. The Burden of Musculoskeletal Conditions at the Start of the New Millenium, Technical Report Series,No.919. Geneva: World Health Organization; 2003.
2.
Zurück zum Zitat Lesuis N, Befrits R, Nyberg F, van Vollenhoven RF. Gender and the treatment of immune-mediated chronic inflammatory diseases: rheumatoid arthritis, inflammatory bowel disease and psoriasis: an observational study. BMC Med. 2012;10:82.CrossRefPubMedCentralPubMed Lesuis N, Befrits R, Nyberg F, van Vollenhoven RF. Gender and the treatment of immune-mediated chronic inflammatory diseases: rheumatoid arthritis, inflammatory bowel disease and psoriasis: an observational study. BMC Med. 2012;10:82.CrossRefPubMedCentralPubMed
3.
Zurück zum Zitat Cutolo M, Kitas GD, van Riel PL. Burden of disease in treated rheumatoid arthritis patients: Going beyond the joint. Semin Arthritis Rheum. 2014;43:479–88.CrossRefPubMed Cutolo M, Kitas GD, van Riel PL. Burden of disease in treated rheumatoid arthritis patients: Going beyond the joint. Semin Arthritis Rheum. 2014;43:479–88.CrossRefPubMed
4.
Zurück zum Zitat Demmelmaier I, Bergman P, Nordgren B, Jensen I, Opava CH. Current and maintained health-enhancing physical activity in rheumatoid arthritis: a cross-sectional study. Arthritis Care Res (Hoboken). 2013;65:1166–76.CrossRef Demmelmaier I, Bergman P, Nordgren B, Jensen I, Opava CH. Current and maintained health-enhancing physical activity in rheumatoid arthritis: a cross-sectional study. Arthritis Care Res (Hoboken). 2013;65:1166–76.CrossRef
5.
Zurück zum Zitat Dickens C, McGowan L, Clark-Carter D, Creed F. Depression in rheumatoid arthritis: A systematic review of the literature with meta-analysis. Psychosom Med. 2002;64:52–60.CrossRefPubMed Dickens C, McGowan L, Clark-Carter D, Creed F. Depression in rheumatoid arthritis: A systematic review of the literature with meta-analysis. Psychosom Med. 2002;64:52–60.CrossRefPubMed
6.
Zurück zum Zitat WHO. ICF - International Classification of Functioning, Disability and Health. Geneva: World Health Organization; 2001. WHO. ICF - International Classification of Functioning, Disability and Health. Geneva: World Health Organization; 2001.
7.
Zurück zum Zitat WHO. How to use the ICF: A practical manual for using the International Classification of Functioning, Disability and Health (ICF). Exposure draft for comment. Geneva: World Health Organization; 2013. WHO. How to use the ICF: A practical manual for using the International Classification of Functioning, Disability and Health (ICF). Exposure draft for comment. Geneva: World Health Organization; 2013.
8.
Zurück zum Zitat Grotkamp S, Cibis W, Nuchtern E, von Mittelstaedt G, Seger W. Personal Factors in the International Classification of Functioning, Disability and Health: Prospective Evidence. Aust J Rehab Couns. 2012;18:1–24.CrossRef Grotkamp S, Cibis W, Nuchtern E, von Mittelstaedt G, Seger W. Personal Factors in the International Classification of Functioning, Disability and Health: Prospective Evidence. Aust J Rehab Couns. 2012;18:1–24.CrossRef
9.
Zurück zum Zitat Geyh S, Peter C, Muller R, Bickenbach JE, Kostanjsek N, Ustun BT, et al. The Personal Factors of the International Classification of Functioning, Disability and Health in the literature - a systematic review and content analysis. Disabil Rehabil. 2011;33:1089–102.CrossRefPubMed Geyh S, Peter C, Muller R, Bickenbach JE, Kostanjsek N, Ustun BT, et al. The Personal Factors of the International Classification of Functioning, Disability and Health in the literature - a systematic review and content analysis. Disabil Rehabil. 2011;33:1089–102.CrossRefPubMed
10.
Zurück zum Zitat Ng L, Khan F. Identification of personal factors in motor neurone disease: a pilot study. Rehabil Res Pract. 2011;2011:7. Ng L, Khan F. Identification of personal factors in motor neurone disease: a pilot study. Rehabil Res Pract. 2011;2011:7.
11.
Zurück zum Zitat Stucki G, Cieza A, Geyh S, Battistella L, Lloyd J, Symmons D, et al. ICF Core Sets for rheumatoid arthritis. J Rehabil Med. 2004;(44 Suppl):87–93. Stucki G, Cieza A, Geyh S, Battistella L, Lloyd J, Symmons D, et al. ICF Core Sets for rheumatoid arthritis. J Rehabil Med. 2004;(44 Suppl):87–93.
12.
Zurück zum Zitat Gebhardt C, Kirchberger I, Stucki G, Cieza A. Validation of the comprehensive ICF Core Set for rheumatoid arthritis: The perspective of physicians. J Rehabil Med. 2010;42:780–8.CrossRefPubMed Gebhardt C, Kirchberger I, Stucki G, Cieza A. Validation of the comprehensive ICF Core Set for rheumatoid arthritis: The perspective of physicians. J Rehabil Med. 2010;42:780–8.CrossRefPubMed
13.
Zurück zum Zitat Kirchberger I, Cieza A, Stucki G. Validation of the Comprehensive ICF Core Set for rheumatoid arthritis: The perspective of psychologists. Psychol Health. 2008;23:639–59.CrossRefPubMed Kirchberger I, Cieza A, Stucki G. Validation of the Comprehensive ICF Core Set for rheumatoid arthritis: The perspective of psychologists. Psychol Health. 2008;23:639–59.CrossRefPubMed
14.
Zurück zum Zitat Coenen M, Cieza A, Stamm TA, Amann E, Kollerits B, Stucki G. Validation of the International Classification of Functioning, Disability and Health (ICF) Core Set for rheumatoid arthritis from the patient perspective using focus groups. Arthritis Res Ther. 2006;8:R84.CrossRefPubMedCentralPubMed Coenen M, Cieza A, Stamm TA, Amann E, Kollerits B, Stucki G. Validation of the International Classification of Functioning, Disability and Health (ICF) Core Set for rheumatoid arthritis from the patient perspective using focus groups. Arthritis Res Ther. 2006;8:R84.CrossRefPubMedCentralPubMed
15.
Zurück zum Zitat Stamm TA, Cieza A, Coenen M, Machold KP, Nell VP, Smolen JS, et al. Validating the International Classification of Functioning, Disability and Health Comprehensive Core Set for Rheumatoid Arthritis from the patient perspective: A qualitative study. Arthritis Rheum. 2005;53:431–9.CrossRefPubMed Stamm TA, Cieza A, Coenen M, Machold KP, Nell VP, Smolen JS, et al. Validating the International Classification of Functioning, Disability and Health Comprehensive Core Set for Rheumatoid Arthritis from the patient perspective: A qualitative study. Arthritis Rheum. 2005;53:431–9.CrossRefPubMed
16.
Zurück zum Zitat Ahlstrand I, Bjork M, Thyberg I, Borsbo B, Falkmer T. Pain and daily activities in rheumatoid arthritis. Disabil Rehabil. 2012;34:1245–53.CrossRefPubMed Ahlstrand I, Bjork M, Thyberg I, Borsbo B, Falkmer T. Pain and daily activities in rheumatoid arthritis. Disabil Rehabil. 2012;34:1245–53.CrossRefPubMed
17.
Zurück zum Zitat Primdahl J, Wagner L, Horslev-Petersen K. Being an outpatient with rheumatoid arthritis–a focus group study on patients’ self-efficacy and experiences from participation in a short course and one of three different outpatient settings. Scand J Caring Sci. 2011;25:394–403.CrossRefPubMed Primdahl J, Wagner L, Horslev-Petersen K. Being an outpatient with rheumatoid arthritis–a focus group study on patients’ self-efficacy and experiences from participation in a short course and one of three different outpatient settings. Scand J Caring Sci. 2011;25:394–403.CrossRefPubMed
18.
Zurück zum Zitat Kuspinar A, Mayo NE. Do generic utility measures capture what is important to the quality of life of people with multiple sclerosis? Health Qual Life Outcomes. 2013;11:71.CrossRefPubMedCentralPubMed Kuspinar A, Mayo NE. Do generic utility measures capture what is important to the quality of life of people with multiple sclerosis? Health Qual Life Outcomes. 2013;11:71.CrossRefPubMedCentralPubMed
19.
Zurück zum Zitat Stamm TA, Nell V, Mathis M, Coenen M, Aletaha D, Cieza A, et al. Concepts important to patients with psoriatic arthritis are not adequately covered by standard measures of functioning. Arthritis Rheum. 2007;57:487–94.CrossRefPubMed Stamm TA, Nell V, Mathis M, Coenen M, Aletaha D, Cieza A, et al. Concepts important to patients with psoriatic arthritis are not adequately covered by standard measures of functioning. Arthritis Rheum. 2007;57:487–94.CrossRefPubMed
20.
Zurück zum Zitat Stamm TA, Bauernfeind B, Coenen M, Feierl E, Mathis M, Stucki G, et al. Concepts important to persons with systemic lupus erythematosus and their coverage by standard measures of disease activity and health status. Arthritis Rheum. 2007;57:1287–95.CrossRefPubMed Stamm TA, Bauernfeind B, Coenen M, Feierl E, Mathis M, Stucki G, et al. Concepts important to persons with systemic lupus erythematosus and their coverage by standard measures of disease activity and health status. Arthritis Rheum. 2007;57:1287–95.CrossRefPubMed
21.
Zurück zum Zitat Lazarus RS, Folkman S. Stress, Appraisal, and Coping. New York: Springer; 1984. Lazarus RS, Folkman S. Stress, Appraisal, and Coping. New York: Springer; 1984.
23.
Zurück zum Zitat Meesters J, Verhoef J, Tijhuis G, Vliet Vlieland T. Functional disability in patients with rheumatoid arthritis admitted for multidisciplinary rehabilitation from 1992 to 2009. Rheumatology (Oxford). 2013;52:1879–83.CrossRef Meesters J, Verhoef J, Tijhuis G, Vliet Vlieland T. Functional disability in patients with rheumatoid arthritis admitted for multidisciplinary rehabilitation from 1992 to 2009. Rheumatology (Oxford). 2013;52:1879–83.CrossRef
24.
Zurück zum Zitat Woolf AD, Erwin J, March L. The need to address the burden of musculoskeletal conditions. Best Pract Res Clin Rheumatol. 2012;26:183–224.CrossRefPubMed Woolf AD, Erwin J, March L. The need to address the burden of musculoskeletal conditions. Best Pract Res Clin Rheumatol. 2012;26:183–224.CrossRefPubMed
25.
Zurück zum Zitat Englbrecht M, Gossec L, DeLongis A, Scholte-Voshaar M, Sokka T, Kvien TK, et al. The impact of coping strategies on mental and physical well-being in patients with rheumatoid arthritis. Semin Arthritis Rheum. 2012;41:545–55.CrossRefPubMed Englbrecht M, Gossec L, DeLongis A, Scholte-Voshaar M, Sokka T, Kvien TK, et al. The impact of coping strategies on mental and physical well-being in patients with rheumatoid arthritis. Semin Arthritis Rheum. 2012;41:545–55.CrossRefPubMed
26.
Zurück zum Zitat Zwikker HE, van den Ende CH, van Lankveld WG, den Broeder AA, van den Hoogen FH, van de Mosselaar B, et al. Effectiveness of a group-based intervention to change medication beliefs and improve medication adherence in patients with rheumatoid arthritis: a randomized controlled trial. Patient Educ Couns. 2014;94:356–61.CrossRefPubMed Zwikker HE, van den Ende CH, van Lankveld WG, den Broeder AA, van den Hoogen FH, van de Mosselaar B, et al. Effectiveness of a group-based intervention to change medication beliefs and improve medication adherence in patients with rheumatoid arthritis: a randomized controlled trial. Patient Educ Couns. 2014;94:356–61.CrossRefPubMed
27.
Zurück zum Zitat Dür M, Steiner G, Fialka-Moser V, Kautzky-Willer A, Dejaco C, Prodinger B, et al. Development of a new occupational balance-questionnaire: incorporating the perspectives of patients and healthy people in the design of a self-reported occupational balance outcome instrument. Health Qual Life Outcomes. 2014;12:45.CrossRefPubMedCentralPubMed Dür M, Steiner G, Fialka-Moser V, Kautzky-Willer A, Dejaco C, Prodinger B, et al. Development of a new occupational balance-questionnaire: incorporating the perspectives of patients and healthy people in the design of a self-reported occupational balance outcome instrument. Health Qual Life Outcomes. 2014;12:45.CrossRefPubMedCentralPubMed
28.
Zurück zum Zitat Dür M, Sadlonova M, Haider S, Binder A, Stoffer M, Coenen M, et al. Health determining concepts important to people with Crohn’s disease and their coverage by patient-reported outcomes of health and wellbeing. J Crohns Colitis. 2014;8:45–55.CrossRefPubMedCentralPubMed Dür M, Sadlonova M, Haider S, Binder A, Stoffer M, Coenen M, et al. Health determining concepts important to people with Crohn’s disease and their coverage by patient-reported outcomes of health and wellbeing. J Crohns Colitis. 2014;8:45–55.CrossRefPubMedCentralPubMed
29.
Zurück zum Zitat Stamm TA, Lovelock L, Stew G, Nell V, Smolen J, Machold K, et al. I have a disease but I am not ill: A narrative study of occupational balance in people with rheumatoid arthritis. OTJR. 2009;29:32–9. Stamm TA, Lovelock L, Stew G, Nell V, Smolen J, Machold K, et al. I have a disease but I am not ill: A narrative study of occupational balance in people with rheumatoid arthritis. OTJR. 2009;29:32–9.
30.
Zurück zum Zitat Stamm T, Lovelock L, Stew G, Nell V, Smolen J, Jonsson H, et al. I have mastered the challenge of living with a chronic disease: Life stories of people with rheumatoid arthritis. Qual Health Res. 2008;18:658–69.CrossRefPubMed Stamm T, Lovelock L, Stew G, Nell V, Smolen J, Jonsson H, et al. I have mastered the challenge of living with a chronic disease: Life stories of people with rheumatoid arthritis. Qual Health Res. 2008;18:658–69.CrossRefPubMed
31.
Zurück zum Zitat Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum. 1988;31:315–24.CrossRefPubMed Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum. 1988;31:315–24.CrossRefPubMed
32.
Zurück zum Zitat Jones K. The turn to a narrative knowing of persons: One method explored. Nurs Time Res. 2002;1:1–11. Jones K. The turn to a narrative knowing of persons: One method explored. Nurs Time Res. 2002;1:1–11.
33.
Zurück zum Zitat Wengraf T. Qualitative Research Interviewing: Biographic Narratives and Semi-Structured Methods. London: Sage Publications; 2001.CrossRef Wengraf T. Qualitative Research Interviewing: Biographic Narratives and Semi-Structured Methods. London: Sage Publications; 2001.CrossRef
34.
Zurück zum Zitat Rosenthal G. Reconstruction of Life Stories. Principles of Selection in Generating Stories of Narrative Biographical Interviews. In: Josselson R, Lieblich A, editors. The Narrative Study of Lives. Thousand Oaks: Sage; 1993. p. 59–91. Rosenthal G. Reconstruction of Life Stories. Principles of Selection in Generating Stories of Narrative Biographical Interviews. In: Josselson R, Lieblich A, editors. The Narrative Study of Lives. Thousand Oaks: Sage; 1993. p. 59–91.
35.
Zurück zum Zitat Cieza A, Geyh S, Chatterji S, Kostanjsek N, Ustun B, Stucki G. ICF linking rules: an update based on lessons learned. J Rehabil Med. 2005;37:212–8.CrossRefPubMed Cieza A, Geyh S, Chatterji S, Kostanjsek N, Ustun B, Stucki G. ICF linking rules: an update based on lessons learned. J Rehabil Med. 2005;37:212–8.CrossRefPubMed
36.
Zurück zum Zitat Meenan RF, Mason JH, Anderson JJ, Guccione AA, Kazis LE. AIMS2. The content and properties of a revised and expanded Arthritis Impact Measurement Scales Health Status Questionnaire. Arthritis Rheum. 1992;35:1–10.CrossRefPubMed Meenan RF, Mason JH, Anderson JJ, Guccione AA, Kazis LE. AIMS2. The content and properties of a revised and expanded Arthritis Impact Measurement Scales Health Status Questionnaire. Arthritis Rheum. 1992;35:1–10.CrossRefPubMed
37.
Zurück zum Zitat Li T, Wells G, Westhovens R, Tugwell P. Validation of a simple activity participation measure for rheumatoid arthritis clinical trials. Rheumatology (Oxford). 2009;48:170–5.CrossRef Li T, Wells G, Westhovens R, Tugwell P. Validation of a simple activity participation measure for rheumatoid arthritis clinical trials. Rheumatology (Oxford). 2009;48:170–5.CrossRef
38.
Zurück zum Zitat Lorig K, Chastain RL, Ung E, Shoor S, Holman HR. Development and evaluation of a scale to measure perceived self-efficacy in people with arthritis. Arthritis Rheum. 1989;32:37–44.CrossRefPubMed Lorig K, Chastain RL, Ung E, Shoor S, Holman HR. Development and evaluation of a scale to measure perceived self-efficacy in people with arthritis. Arthritis Rheum. 1989;32:37–44.CrossRefPubMed
39.
Zurück zum Zitat Newth S, Delongis A. Individual differences, mood, and coping with chronic pain in rheumatoid arthritis: A daily process analysis. Psychol Health. 2004;19:283–305.CrossRef Newth S, Delongis A. Individual differences, mood, and coping with chronic pain in rheumatoid arthritis: A daily process analysis. Psychol Health. 2004;19:283–305.CrossRef
40.
Zurück zum Zitat Nicklin J, Cramp F, Kirwan J, Urban M, Hewlett S. Collaboration with patients in the design of patient-reported outcome measures: capturing the experience of fatigue in rheumatoid arthritis. Arthritis Care Res (Hoboken). 2010;62:1552–8.CrossRef Nicklin J, Cramp F, Kirwan J, Urban M, Hewlett S. Collaboration with patients in the design of patient-reported outcome measures: capturing the experience of fatigue in rheumatoid arthritis. Arthritis Care Res (Hoboken). 2010;62:1552–8.CrossRef
41.
Zurück zum Zitat Chalder T, Berelowitz G, Pawlikowska T, Watts L, Wessely S, Wright D, et al. Development of a fatigue scale. J Psychosom Res. 1993;37:147–53.CrossRefPubMed Chalder T, Berelowitz G, Pawlikowska T, Watts L, Wessely S, Wright D, et al. Development of a fatigue scale. J Psychosom Res. 1993;37:147–53.CrossRefPubMed
42.
Zurück zum Zitat Vercoulen JHMM, Swanink CMA, Fennis JFM, Galama JMD, Vandermeer JWM, Bleijenberg G. Dimensional Assessment of Chronic Fatigue Syndrome. J Psychosom Res. 1994;38:383–92.CrossRefPubMed Vercoulen JHMM, Swanink CMA, Fennis JFM, Galama JMD, Vandermeer JWM, Bleijenberg G. Dimensional Assessment of Chronic Fatigue Syndrome. J Psychosom Res. 1994;38:383–92.CrossRefPubMed
43.
Zurück zum Zitat Carr A. A Patient-centred Approach to Evaluation and Treatment in Rheumatoid Arthritis: the Development of a Clinical Tool to Measure Patient-perceived Handicap. Br J Rheumatol. 1996;35:921–32.CrossRefPubMed Carr A. A Patient-centred Approach to Evaluation and Treatment in Rheumatoid Arthritis: the Development of a Clinical Tool to Measure Patient-perceived Handicap. Br J Rheumatol. 1996;35:921–32.CrossRefPubMed
44.
Zurück zum Zitat Kristjansson E, Tugwell PS, Wilson AJ, Brooks PM, Driedger SM, Gallois C, et al. Development of the effective musculoskeletal consumer scale. J Rheumatol. 2007;34:1392–400.PubMed Kristjansson E, Tugwell PS, Wilson AJ, Brooks PM, Driedger SM, Gallois C, et al. Development of the effective musculoskeletal consumer scale. J Rheumatol. 2007;34:1392–400.PubMed
45.
Zurück zum Zitat Rabin R, de Charro F. EQ-5D: a measure of health status from the EuroQol Group. Ann Med. 2001;33:337–43.CrossRefPubMed Rabin R, de Charro F. EQ-5D: a measure of health status from the EuroQol Group. Ann Med. 2001;33:337–43.CrossRefPubMed
46.
Zurück zum Zitat Yellen SB, Cella DF, Webster K, Blendowski C, Kaplan E. Measuring fatigue and other anemia-related symptoms with the Functional Assessment of Cancer Therapy (FACT) measurement system. J Pain Symptom Manage. 1997;13:63–74.CrossRefPubMed Yellen SB, Cella DF, Webster K, Blendowski C, Kaplan E. Measuring fatigue and other anemia-related symptoms with the Functional Assessment of Cancer Therapy (FACT) measurement system. J Pain Symptom Manage. 1997;13:63–74.CrossRefPubMed
47.
Zurück zum Zitat Krupp LB, LaRocca NG, Muir-Nash J, Steinberg AD. The fatigue severity scale. Application to patients with multiple sclerosis and systemic lupus erythematosus. Arch Neurol. 1989;46:1121–3.CrossRefPubMed Krupp LB, LaRocca NG, Muir-Nash J, Steinberg AD. The fatigue severity scale. Application to patients with multiple sclerosis and systemic lupus erythematosus. Arch Neurol. 1989;46:1121–3.CrossRefPubMed
48.
Zurück zum Zitat Jerusalem M, Schwarzer R. Self-efficacy as a resource factor in stress appraisal processes. In: Schwarzer R, editor. Self-Efficacy: Thought Control of Action. Washington DC: Hemisphere; 1992. Jerusalem M, Schwarzer R. Self-efficacy as a resource factor in stress appraisal processes. In: Schwarzer R, editor. Self-Efficacy: Thought Control of Action. Washington DC: Hemisphere; 1992.
49.
Zurück zum Zitat Schwarzer R. Measurement of Perceived Self-Efficacy: Psychometric Scales for Cross-Cultural Research. Berlin: Freie Universität Berlin, Institut für Psychologie; 1993. Schwarzer R. Measurement of Perceived Self-Efficacy: Psychometric Scales for Cross-Cultural Research. Berlin: Freie Universität Berlin, Institut für Psychologie; 1993.
50.
Zurück zum Zitat Zigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta Psychiatr Scand. 1983;67:361–70.CrossRefPubMed Zigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta Psychiatr Scand. 1983;67:361–70.CrossRefPubMed
51.
Zurück zum Zitat Fries JF, Spitz P, Kraines RG, Holman HR. Measurement of patient outcome in arthritis. Arthritis Rheum. 1980;23:137–45.CrossRefPubMed Fries JF, Spitz P, Kraines RG, Holman HR. Measurement of patient outcome in arthritis. Arthritis Rheum. 1980;23:137–45.CrossRefPubMed
52.
Zurück zum Zitat Wolfe F, Michaud K, Pincus T. Development and validation of the health assessment questionnaire II: A revised version of the health assessment questionnaire. Arthritis Rheum. 2004;50:3296–305.CrossRefPubMed Wolfe F, Michaud K, Pincus T. Development and validation of the health assessment questionnaire II: A revised version of the health assessment questionnaire. Arthritis Rheum. 2004;50:3296–305.CrossRefPubMed
53.
Zurück zum Zitat Fries JF, Spitz PW, Young DY. The dimensions of health outcomes: The health assessment questionnaire, disability and pain scales. J Rheumatol. 1982;9:789–93.PubMed Fries JF, Spitz PW, Young DY. The dimensions of health outcomes: The health assessment questionnaire, disability and pain scales. J Rheumatol. 1982;9:789–93.PubMed
54.
Zurück zum Zitat Niedermann K, Forster A, Ciurea A, Hammond A, Uebelhart D, de Bie R. Development and psychometric properties of a joint protection self-efficacy scale. Scand J Occup Ther. 2011;18:143–52.CrossRefPubMed Niedermann K, Forster A, Ciurea A, Hammond A, Uebelhart D, de Bie R. Development and psychometric properties of a joint protection self-efficacy scale. Scand J Occup Ther. 2011;18:143–52.CrossRefPubMed
55.
Zurück zum Zitat Newman S, Fitzpatrick R, Lamb R, Shipley M. Patterns of Coping in Rheumatoid Arthritis. Psychol Health. 1990;4:187–200.CrossRef Newman S, Fitzpatrick R, Lamb R, Shipley M. Patterns of Coping in Rheumatoid Arthritis. Psychol Health. 1990;4:187–200.CrossRef
56.
Zurück zum Zitat Scheier MF, Carver CS. Optimism, coping, and health: assessment and implications of generalized outcome expectancies. Health Psychol. 1985;4:219–47.CrossRefPubMed Scheier MF, Carver CS. Optimism, coping, and health: assessment and implications of generalized outcome expectancies. Health Psychol. 1985;4:219–47.CrossRefPubMed
57.
Zurück zum Zitat Tack B. Dimensions and correlates of fatigue in older adults with rheumatoid arthritis. San Francisco: University of California; 1991. Tack B. Dimensions and correlates of fatigue in older adults with rheumatoid arthritis. San Francisco: University of California; 1991.
58.
Zurück zum Zitat Smets EM, Garssen B, Bonke B, De Haes JC. The Multidimensional Fatigue Inventory (MFI) psychometric qualities of an instrument to assess fatigue. J Psychosom Res. 1995;39:315–25.CrossRefPubMed Smets EM, Garssen B, Bonke B, De Haes JC. The Multidimensional Fatigue Inventory (MFI) psychometric qualities of an instrument to assess fatigue. J Psychosom Res. 1995;39:315–25.CrossRefPubMed
59.
Zurück zum Zitat Pincus T, Summey JA, Soraci Jr SA, Wallston KA, Hummon NP. Assessment of patient satisfaction in activities of daily living using a modified Stanford Health Assessment Questionnaire. Arthritis Rheum. 1983;26:1346–53.CrossRefPubMed Pincus T, Summey JA, Soraci Jr SA, Wallston KA, Hummon NP. Assessment of patient satisfaction in activities of daily living using a modified Stanford Health Assessment Questionnaire. Arthritis Rheum. 1983;26:1346–53.CrossRefPubMed
60.
Zurück zum Zitat Wallston KA, Stein MJ, Smith CA. Form C of the MHLC scales: a condition-specific measure of locus of control. J Pers Assess. 1994;63:534–53.CrossRefPubMed Wallston KA, Stein MJ, Smith CA. Form C of the MHLC scales: a condition-specific measure of locus of control. J Pers Assess. 1994;63:534–53.CrossRefPubMed
61.
Zurück zum Zitat Hewlett S, Smith AP, Kirwan JR. Measuring the meaning of disability in rheumatoid arthritis: the Personal Impact Health Assessment Questionnaire (PI HAQ). Ann Rheum Dis. 2002;61:986–93.CrossRefPubMedCentralPubMed Hewlett S, Smith AP, Kirwan JR. Measuring the meaning of disability in rheumatoid arthritis: the Personal Impact Health Assessment Questionnaire (PI HAQ). Ann Rheum Dis. 2002;61:986–93.CrossRefPubMedCentralPubMed
62.
Zurück zum Zitat Salaffi F, Migliore A, Scarpellini M, Corsaro SM, Lagana B, Mozzani F, et al. Psychometric properties of an index of three patient reported outcome (PRO) measures, termed the CLinical ARthritis Activity (PRO-CLARA) in patients with rheumatoid arthritis. The NEW INDICES study. Clin Exp Rheumatol. 2010;28:186–200.PubMed Salaffi F, Migliore A, Scarpellini M, Corsaro SM, Lagana B, Mozzani F, et al. Psychometric properties of an index of three patient reported outcome (PRO) measures, termed the CLinical ARthritis Activity (PRO-CLARA) in patients with rheumatoid arthritis. The NEW INDICES study. Clin Exp Rheumatol. 2010;28:186–200.PubMed
63.
Zurück zum Zitat Gossec L, Dougados M, Rincheval N, Balanescu A, Boumpas DT, Canadelo S, et al. Elaboration of the preliminary Rheumatoid Arthritis Impact of Disease (RAID) score: a EULAR initiative. Ann Rheum Dis. 2009;68:1680–5.CrossRefPubMed Gossec L, Dougados M, Rincheval N, Balanescu A, Boumpas DT, Canadelo S, et al. Elaboration of the preliminary Rheumatoid Arthritis Impact of Disease (RAID) score: a EULAR initiative. Ann Rheum Dis. 2009;68:1680–5.CrossRefPubMed
64.
Zurück zum Zitat Pincus T, Swearingen CJ, Bergman M, Yazici Y. RAPID3 (Routine Assessment of Patient Index Data 3), a rheumatoid arthritis index without formal joint counts for routine care: proposed severity categories compared to disease activity score and clinical disease activity index categories. J Rheumatol. 2008;35:2136–47.CrossRefPubMed Pincus T, Swearingen CJ, Bergman M, Yazici Y. RAPID3 (Routine Assessment of Patient Index Data 3), a rheumatoid arthritis index without formal joint counts for routine care: proposed severity categories compared to disease activity score and clinical disease activity index categories. J Rheumatol. 2008;35:2136–47.CrossRefPubMed
65.
Zurück zum Zitat Whalley D, McKenna SP, de Jong Z, van der Heijde D. Quality of life in rheumatoid arthritis. Br J Rheumatol. 1997;36:884–8.CrossRefPubMed Whalley D, McKenna SP, de Jong Z, van der Heijde D. Quality of life in rheumatoid arthritis. Br J Rheumatol. 1997;36:884–8.CrossRefPubMed
66.
Zurück zum Zitat Salaffi F, Bazzichi L, Stancati A, Neri R, Cazzato M, Consensi A, et al. Development of a functional disability measurement tool to assess early arthritis: the Recent-Onset Arthritis Disability (ROAD) questionnaire. Clin Exp Rheumatol. 2005;23:628–36.PubMed Salaffi F, Bazzichi L, Stancati A, Neri R, Cazzato M, Consensi A, et al. Development of a functional disability measurement tool to assess early arthritis: the Recent-Onset Arthritis Disability (ROAD) questionnaire. Clin Exp Rheumatol. 2005;23:628–36.PubMed
67.
Zurück zum Zitat Hewlett S, Cockshott Z, Kirwan J, Barrett J, Stamp J, Haslock I. Development and validation of a self-efficacy scale for use in British patients with rheumatoid arthritis (RASE). Rheumatology (Oxford). 2001;40:1221–30.CrossRef Hewlett S, Cockshott Z, Kirwan J, Barrett J, Stamp J, Haslock I. Development and validation of a self-efficacy scale for use in British patients with rheumatoid arthritis (RASE). Rheumatology (Oxford). 2001;40:1221–30.CrossRef
68.
Zurück zum Zitat Leeb BF, Sautner J, Andel I, Rintelen B. SACRAH: a score for assessment and quantification of chronic rheumatic affections of the hands. Rheumatology (Oxford). 2003;42:1173–8.CrossRef Leeb BF, Sautner J, Andel I, Rintelen B. SACRAH: a score for assessment and quantification of chronic rheumatic affections of the hands. Rheumatology (Oxford). 2003;42:1173–8.CrossRef
69.
Zurück zum Zitat Ware JE. How to Score the Revised MOS Short-Form Health Scale (SF-36®). Boston, MA: The Health Institute, New England Medical Center Hospitals; 1988. Ware JE. How to Score the Revised MOS Short-Form Health Scale (SF-36®). Boston, MA: The Health Institute, New England Medical Center Hospitals; 1988.
70.
Zurück zum Zitat Ware Jr JE, Sherbourne CD. The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care. 1992;30:473–83.CrossRefPubMed Ware Jr JE, Sherbourne CD. The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care. 1992;30:473–83.CrossRefPubMed
71.
Zurück zum Zitat Antonovsky A. The structure and properties of the sense of coherence scale. Soc Sci Med. 1993;36:725–33.CrossRefPubMed Antonovsky A. The structure and properties of the sense of coherence scale. Soc Sci Med. 1993;36:725–33.CrossRefPubMed
72.
Zurück zum Zitat Suurmeijer TP, Doeglas DM, Briancon S, Krijnen WP, Krol B, Sanderman R, et al. The measurement of social support in the ‘European Research on Incapacitating Diseases and Social Support’: the development of the Social Support Questionnaire for Transactions (SSQT). Soc Sci Med. 1995;40:1221–9.CrossRefPubMed Suurmeijer TP, Doeglas DM, Briancon S, Krijnen WP, Krol B, Sanderman R, et al. The measurement of social support in the ‘European Research on Incapacitating Diseases and Social Support’: the development of the Social Support Questionnaire for Transactions (SSQT). Soc Sci Med. 1995;40:1221–9.CrossRefPubMed
73.
74.
Zurück zum Zitat Folkman S, Lazarus RS. If it changes it must be a process: Study of emotion and coping during three stages of a college examination. J Pers Soc Psychol. 1985;48:150–70.CrossRefPubMed Folkman S, Lazarus RS. If it changes it must be a process: Study of emotion and coping during three stages of a college examination. J Pers Soc Psychol. 1985;48:150–70.CrossRefPubMed
75.
Zurück zum Zitat Pincus T, Swearingen C, Wolfe F. Toward a multidimensional Health Assessment Questionnaire (MDHAQ): assessment of advanced activities of daily living and psychological status in the patient-friendly health assessment questionnaire format. Arthritis Rheum. 1999;42:2220–30.CrossRefPubMed Pincus T, Swearingen C, Wolfe F. Toward a multidimensional Health Assessment Questionnaire (MDHAQ): assessment of advanced activities of daily living and psychological status in the patient-friendly health assessment questionnaire format. Arthritis Rheum. 1999;42:2220–30.CrossRefPubMed
76.
Zurück zum Zitat Sautner J, Andel I, Rintelen B, Leeb BF. Development of the M-SACRAH, a modified, shortened version of SACRAH (Score for the Assessment and Quantification of Chronic Rheumatoid Affections of the Hands). Rheumatology (Oxford). 2004;43:1409–13.CrossRef Sautner J, Andel I, Rintelen B, Leeb BF. Development of the M-SACRAH, a modified, shortened version of SACRAH (Score for the Assessment and Quantification of Chronic Rheumatoid Affections of the Hands). Rheumatology (Oxford). 2004;43:1409–13.CrossRef
77.
Zurück zum Zitat Stamm T, Geyh S, Cieza A, Machold K, Kollerits B, Kloppenburg M, et al. Measuring functioning in patients with hand osteoarthritis–content comparison of questionnaires based on the International Classification of Functioning, Disability and Health (ICF). Rheumatology (Oxford). 2006;45:1534–41.CrossRef Stamm T, Geyh S, Cieza A, Machold K, Kollerits B, Kloppenburg M, et al. Measuring functioning in patients with hand osteoarthritis–content comparison of questionnaires based on the International Classification of Functioning, Disability and Health (ICF). Rheumatology (Oxford). 2006;45:1534–41.CrossRef
78.
Zurück zum Zitat Cieza A, Stucki G. Content comparison of health-related quality of life (HRQOL) instruments based on the international classification of functioning, disability and health (ICF). Qual Life Res. 2005;14:1225–37.CrossRefPubMed Cieza A, Stucki G. Content comparison of health-related quality of life (HRQOL) instruments based on the international classification of functioning, disability and health (ICF). Qual Life Res. 2005;14:1225–37.CrossRefPubMed
79.
Zurück zum Zitat Folkman S, Lazarus RS. An analysis of coping in a middle-aged community sample. J Health Soc Behav. 1980;21:219–39.CrossRefPubMed Folkman S, Lazarus RS. An analysis of coping in a middle-aged community sample. J Health Soc Behav. 1980;21:219–39.CrossRefPubMed
81.
Zurück zum Zitat Brekke M, Hjortdahl P, Kvien TK. Changes in self-efficacy and health status over 5 years: A longitudinal observational study of 306 patients with rheumatoid arthritis. Arthritis Rheum. 2003;49:342–8.CrossRefPubMed Brekke M, Hjortdahl P, Kvien TK. Changes in self-efficacy and health status over 5 years: A longitudinal observational study of 306 patients with rheumatoid arthritis. Arthritis Rheum. 2003;49:342–8.CrossRefPubMed
82.
Zurück zum Zitat van Hoogmoed D, Fransen J, Bleijenberg G, van Riel P. Physical and psychosocial correlates of severe fatigue in rheumatoid arthritis. Rheumatology (Oxford). 2010;49:1294–302.CrossRef van Hoogmoed D, Fransen J, Bleijenberg G, van Riel P. Physical and psychosocial correlates of severe fatigue in rheumatoid arthritis. Rheumatology (Oxford). 2010;49:1294–302.CrossRef
83.
Zurück zum Zitat Bartoloni E, Alunno A, Bistoni O, Gerli R. Cardiovascular risk in rheumatoid arthritis and systemic autoimmune rheumatic disorders: A suggested model of preventive strategy. Clin Rev Allergy Immunol. 2013;44:14–22.CrossRefPubMed Bartoloni E, Alunno A, Bistoni O, Gerli R. Cardiovascular risk in rheumatoid arthritis and systemic autoimmune rheumatic disorders: A suggested model of preventive strategy. Clin Rev Allergy Immunol. 2013;44:14–22.CrossRefPubMed
84.
Zurück zum Zitat Hurkmans EJ, van den Berg MH, Ronday KH, Peeters AJ, le Cessie S, Vlieland TP. Maintenance of physical activity after Internet-based physical activity interventions in patients with rheumatoid arthritis. Rheumatology (Oxford). 2010;49:167–72.CrossRef Hurkmans EJ, van den Berg MH, Ronday KH, Peeters AJ, le Cessie S, Vlieland TP. Maintenance of physical activity after Internet-based physical activity interventions in patients with rheumatoid arthritis. Rheumatology (Oxford). 2010;49:167–72.CrossRef
85.
Zurück zum Zitat Avina-Zubieta JA, Thomas J, Sadatsafavi M, Lehman AJ, Lacaille D. Risk of incident cardiovascular events in patients with rheumatoid arthritis: A meta-analysis of observational studies. Ann Rheum Dis. 2012;71:1524–9.CrossRefPubMed Avina-Zubieta JA, Thomas J, Sadatsafavi M, Lehman AJ, Lacaille D. Risk of incident cardiovascular events in patients with rheumatoid arthritis: A meta-analysis of observational studies. Ann Rheum Dis. 2012;71:1524–9.CrossRefPubMed
86.
Zurück zum Zitat Scrivo R, Vasile M, Muller-Ladner U, Neumann E, Valesini G. Rheumatic Diseases and Obesity: Adipocytokines as Potential Comorbidity Biomarkers for Cardiovascular Diseases. Mediators Inflamm. 2013;2013:808125.CrossRefPubMedCentralPubMed Scrivo R, Vasile M, Muller-Ladner U, Neumann E, Valesini G. Rheumatic Diseases and Obesity: Adipocytokines as Potential Comorbidity Biomarkers for Cardiovascular Diseases. Mediators Inflamm. 2013;2013:808125.CrossRefPubMedCentralPubMed
87.
Zurück zum Zitat Combe B, Landewe R, Lukas C, Bolosiu HD, Breedveld F, Dougados M, et al. EULAR recommendations for the management of early arthritis: report of a task force of the European Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT). Ann Rheum Dis. 2007;66:34–45.CrossRefPubMedCentralPubMed Combe B, Landewe R, Lukas C, Bolosiu HD, Breedveld F, Dougados M, et al. EULAR recommendations for the management of early arthritis: report of a task force of the European Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT). Ann Rheum Dis. 2007;66:34–45.CrossRefPubMedCentralPubMed
88.
Zurück zum Zitat Petersson C, Simeonsson RJ, Enskar K, Huus K. Comparing children’s self-report instruments for health-related quality of life using the International Classification of Functioning, Disability and Health for Children and Youth (ICF-CY). Health Qual Life Outcomes. 2013;11:75.CrossRefPubMedCentralPubMed Petersson C, Simeonsson RJ, Enskar K, Huus K. Comparing children’s self-report instruments for health-related quality of life using the International Classification of Functioning, Disability and Health for Children and Youth (ICF-CY). Health Qual Life Outcomes. 2013;11:75.CrossRefPubMedCentralPubMed
89.
Zurück zum Zitat Mokkink LB, Terwee CB, Patrick DL, Alonso J, Stratford PW, Knol DL, et al. The COSMIN study reached international consensus on taxonomy, terminology, and definitions of measurement properties for health-related patient-reported outcomes. J Clin Epidemiol. 2010;63:737–45.CrossRefPubMed Mokkink LB, Terwee CB, Patrick DL, Alonso J, Stratford PW, Knol DL, et al. The COSMIN study reached international consensus on taxonomy, terminology, and definitions of measurement properties for health-related patient-reported outcomes. J Clin Epidemiol. 2010;63:737–45.CrossRefPubMed
Metadaten
Titel
Do patient-reported outcome measures cover personal factors important to people with rheumatoid arthritis? A mixed methods design using the International Classification of Functioning, Disability and Health as frame of reference
verfasst von
Mona Dür
Michaela Coenen
Michaela Alexandra Stoffer
Veronika Fialka-Moser
Alexandra Kautzky-Willer
Ingvild Kjeken
Răzvan Gabriel Drăgoi
Malin Mattsson
Carina Boström
Josef Smolen
Tanja Alexandra Stamm
Publikationsdatum
01.12.2015
Verlag
BioMed Central
Erschienen in
Health and Quality of Life Outcomes / Ausgabe 1/2015
Elektronische ISSN: 1477-7525
DOI
https://doi.org/10.1186/s12955-015-0214-8

Weitere Artikel der Ausgabe 1/2015

Health and Quality of Life Outcomes 1/2015 Zur Ausgabe